4921 - 4930 of 6230 Results
Title
Year
-
OPENTitle: Vocal changes in a zebra finch model of Parkinson’s disease characterized by alpha-synuclein overexpression in the song-dedicated anterior forebrain pathwayJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 5Start Page: e0265604End Page: e0265604Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0265604Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0265604&type=printableCitation Count: 12
-
OPENTitle: Reliability of Automatic Computer Vision-Based Assessment of Orofacial Kinematics for Telehealth ApplicationsJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 6Issue #: 2Start Page: 71End Page: 82Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000525698Best OA location URL: https://www.karger.com/Article/Pdf/525698Citation Count: 4
-
OPENTitle: Chemosensory Dysfunction 3-Months After COVID-19, Medications and Factors Associated with Complete RecoveryJournal Name: Annals of Otology, Rhinology & LaryngologyPublisher: SAGE PublicationsVol: 132Issue #: 10Start Page: 1177End Page: 1185Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/00034894221138485Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9742352Citation Count: 2
-
OPENTitle: A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson’s Disease Clinical Trial: A Pilot StudyJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 6Issue #: 1Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000521232Best OA location URL: https://www.karger.com/Article/Pdf/521232Citation Count: 10
-
OPENTitle: Quantification of the purinergic P2X7 receptor with [11C]SMW139 improves through correction for brain-penetrating radiometabolitesJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 43Issue #: 2Start Page: 258End Page: 268Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/0271678x221126830Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/0271678X221126830Citation Count: 5
-
OPENTitle: ECTRIMS 2022 – PosterJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 28Issue #: 3_supplStart Page: 130End Page: 691Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/13524585221123687Best OA location URL: https://lirias.kuleuven.be/bitstream/20.500.12942/704893/2/poster_ECTRIMS_RIMS_Oct%202022_Peeters.pdfCitation Count: 20
-
OPENTitle: At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer's Disease and Related ResearchJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 9Issue #: 1Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14283/jpad.2022.7Best OA location URL: https://link.springer.com/content/pdf/10.14283/jpad.2022.7.pdfCitation Count: 1
- Poster Session2022OPENTitle: Poster SessionJournal Name: Rinsho ShinkeigakuPublisher: Societas Neurologica JaponicaVol: 62Issue #: SupplementStart Page: S247End Page: S393Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5692/clinicalneurol.62_supplement_s247Best OA location URL: https://www.jstage.jst.go.jp/article/clinicalneurol/62/Supplement/62_62_supplement_S247/_pdfCitation Count: 2
-
OPENTitle: Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational studyJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 28Issue #: 13Start Page: 2010End Page: 2019Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/13524585221125381Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/13524585221125381Citation Count: 22
-
OPENTitle: 15th Conference Clinical Trials Alzheimer's Disease, November 29–December 2, 2022, San Francisco, CA, USA: Posters (Clinical Trial Alzheimer's Disease)Journal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.14283/jpad.2022.97Best OA location URL: https://doi.org/10.14283/jpad.2022.97Citation Count: 5